Zhengyang Bao
- Clinical Biochemistry top 10%
- Advanced Glycation End Products research 6
- Nephrology top 10%
-
- Galectins and Cancer Biology 3
- Biomarkers in Disease Mechanisms 2
-
- Diabetic Foot Ulcer Assessment and Management 3
-
- Liver Disease Diagnosis and Treatment 3
-
- Blood properties and coagulation 2
-
- Endoplasmic Reticulum Stress and Disease 2
-
- Connective tissue disorders research 2
- Co-authors
- Zhen SunZhongqun WangChen ShaoJinchuan YanLihua LiLili ZhangYaoyao ZhuangYeqiong Xu
- Journals
- Nature Communications (1 paper)American Journal of Physiology-Heart and Circulatory Physiology (1 paper)Advanced Science (1 paper)
- Partner nations
- China
In The Last Decade
Zhengyang Bao
20 papers receiving 363 citations
Peers
Comparison fields: 5 of 59
- Clinical Biochemistry 62
- Nephrology 59
- Immunology 127
- Endocrinology, Diabetes and Metabolism 57
- Cancer Research 46
Countries citing papers authored by Zhengyang Bao
This map shows the geographic impact of Zhengyang Bao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhengyang Bao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhengyang Bao more than expected).
Fields of papers citing papers by Zhengyang Bao
This network shows the impact of papers produced by Zhengyang Bao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhengyang Bao. The network helps show where Zhengyang Bao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhengyang Bao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 6 | |
| 5 | 2024 | 1 | |
| 6 | 2021 | 93 | |
| 7 | 2020 | 5 | |
| 8 | 2020 | 14 | |
| 9 | 2020 | 11 | |
| 10 | 2020 | 22 | |
| 11 | 2020 | 29 | |
| 12 | 2019 | 27 | |
| 13 | 2019 | 27 | |
| 14 | 2019 | 16 | |
| 15 | 2019 | 9 | |
| 16 | 2019 | 19 | |
| 17 | 2018 | 39 | |
| 18 | 2017 | 23 | |
| 19 | 2017 | 12 | |
| 20 | 2017 | 5 |
About Zhengyang Bao
Zhengyang Bao is a scholar working on Clinical Biochemistry, Nephrology and Endocrinology, Diabetes and Metabolism, having authored 22 papers that have together received 364 indexed citations. Recurring topics across this work include Advanced Glycation End Products research (6 papers), Diabetic Foot Ulcer Assessment and Management (3 papers), Liver Disease Diagnosis and Treatment (3 papers), Galectins and Cancer Biology (3 papers), Blood properties and coagulation (2 papers), Biomarkers in Disease Mechanisms (2 papers), Endoplasmic Reticulum Stress and Disease (2 papers) and Connective tissue disorders research (2 papers). The work is most often cited by research in Clinical Biochemistry (62 citations), Nephrology (59 citations) and Immunology (127 citations). Zhengyang Bao has collaborated with scholars based in China. Frequent co-authors include Zhen Sun, Zhongqun Wang, Chen Shao, Jinchuan Yan, Lihua Li, Lili Zhang, Yaoyao Zhuang, Yeqiong Xu, Yilin Zhao and Yanping Zhu. Their work appears in journals such as Nature Communications, American Journal of Physiology-Heart and Circulatory Physiology and Advanced Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.